Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-emptive Tenofovir for Prevention of HBV Reactivation in Lymphoma Patients
NCT02186574Phase 3Unknown
- Sponsor
- University Health Network
- Start
- May 2015
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by University Health Network. Status: unknown.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02186574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02186574.